AR012437A1 - Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion - Google Patents
Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacionInfo
- Publication number
- AR012437A1 AR012437A1 ARP980101734A ARP980101734A AR012437A1 AR 012437 A1 AR012437 A1 AR 012437A1 AR P980101734 A ARP980101734 A AR P980101734A AR P980101734 A ARP980101734 A AR P980101734A AR 012437 A1 AR012437 A1 AR 012437A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- manufacture
- preparation
- compounds
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84348497A | 1997-04-16 | 1997-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012437A1 true AR012437A1 (es) | 2000-10-18 |
Family
ID=25290123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101734A AR012437A1 (es) | 1997-04-16 | 1998-04-15 | Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0975633A1 (xx) |
JP (1) | JP2001520654A (xx) |
KR (1) | KR20010006462A (xx) |
CN (1) | CN1252069A (xx) |
AR (1) | AR012437A1 (xx) |
AU (1) | AU741033B2 (xx) |
BG (1) | BG103853A (xx) |
BR (1) | BR9809056A (xx) |
CA (1) | CA2286592A1 (xx) |
CO (1) | CO4940470A1 (xx) |
HU (1) | HUP0001443A3 (xx) |
IL (1) | IL131617A0 (xx) |
NO (1) | NO995035L (xx) |
NZ (1) | NZ337125A (xx) |
PL (1) | PL336265A1 (xx) |
SK (1) | SK140099A3 (xx) |
TR (1) | TR199902550T2 (xx) |
WO (1) | WO1998046604A1 (xx) |
ZA (1) | ZA983175B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001057040A1 (en) * | 2000-02-03 | 2001-08-09 | Abbott Laboratories | 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
CZ20032416A3 (cs) | 2001-02-12 | 2004-07-14 | F. Hoffmann-La Roche Ag | 6-Substituované pyridopyrimidiny |
CN107744520A (zh) * | 2017-10-25 | 2018-03-02 | 南京多宝生物科技有限公司 | 嘧啶类化合物在制备促进小肠蠕动药物中的应用 |
CN112209924B (zh) * | 2019-07-09 | 2022-04-05 | 中国科学院天津工业生物技术研究所 | 选择性腺苷a1受体拮抗剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB774094A (en) * | 1953-01-02 | 1957-05-08 | Wellcome Found | Improvements in or relating to pyrimidine compounds |
IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
-
1998
- 1998-04-13 IL IL13161798A patent/IL131617A0/xx unknown
- 1998-04-13 BR BR9809056-9A patent/BR9809056A/pt not_active IP Right Cessation
- 1998-04-13 PL PL98336265A patent/PL336265A1/xx unknown
- 1998-04-13 CN CN98804117A patent/CN1252069A/zh active Pending
- 1998-04-13 WO PCT/US1998/007201 patent/WO1998046604A1/en not_active Application Discontinuation
- 1998-04-13 AU AU71080/98A patent/AU741033B2/en not_active Ceased
- 1998-04-13 SK SK1400-99A patent/SK140099A3/sk unknown
- 1998-04-13 CA CA002286592A patent/CA2286592A1/en not_active Abandoned
- 1998-04-13 KR KR1019997009552A patent/KR20010006462A/ko not_active Application Discontinuation
- 1998-04-13 JP JP54408398A patent/JP2001520654A/ja active Pending
- 1998-04-13 HU HU0001443A patent/HUP0001443A3/hu unknown
- 1998-04-13 TR TR1999/02550T patent/TR199902550T2/xx unknown
- 1998-04-13 NZ NZ337125A patent/NZ337125A/en unknown
- 1998-04-13 EP EP98918091A patent/EP0975633A1/en not_active Withdrawn
- 1998-04-15 AR ARP980101734A patent/AR012437A1/es unknown
- 1998-04-15 ZA ZA983175A patent/ZA983175B/xx unknown
- 1998-04-16 CO CO98020978A patent/CO4940470A1/es unknown
-
1999
- 1999-10-15 NO NO995035A patent/NO995035L/no not_active Application Discontinuation
- 1999-11-03 BG BG103853A patent/BG103853A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010006462A (ko) | 2001-01-26 |
EP0975633A1 (en) | 2000-02-02 |
IL131617A0 (en) | 2001-01-28 |
NO995035D0 (no) | 1999-10-15 |
ZA983175B (en) | 1998-10-21 |
BG103853A (en) | 2000-06-30 |
BR9809056A (pt) | 2000-08-01 |
SK140099A3 (en) | 2000-05-16 |
CO4940470A1 (es) | 2000-07-24 |
NO995035L (no) | 1999-12-15 |
TR199902550T2 (xx) | 2000-04-21 |
WO1998046604A1 (en) | 1998-10-22 |
HUP0001443A3 (en) | 2001-01-29 |
AU741033B2 (en) | 2001-11-22 |
AU7108098A (en) | 1998-11-11 |
JP2001520654A (ja) | 2001-10-30 |
CN1252069A (zh) | 2000-05-03 |
PL336265A1 (en) | 2000-06-19 |
HUP0001443A2 (hu) | 2000-10-28 |
NZ337125A (en) | 2001-06-29 |
CA2286592A1 (en) | 1998-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT100631A (pt) | Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem | |
ES2059602T3 (es) | Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral. | |
CA2098076A1 (en) | Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates | |
RU2004130488A (ru) | Пиримидиновые производные | |
UY25225A1 (es) | Derivados de pleuromutilina utiles como agentes antimicrobianos | |
RU94016183A (ru) | Производные пиперазина | |
AR012436A1 (es) | Compuestos de 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos, composicion farmaceutica que los comprende, el uso de los mismos para lamanufactura de medicamentos, un procedimiento para su preparacion. | |
RU93004793A (ru) | Производные хиназолина, способ их получения, фармацевтическая композиция на их основе | |
OA09454A (fr) | Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
ES2046193T3 (es) | Un procedimiento para la preparacion de un compuesto de imidazolidinona. | |
AR012437A1 (es) | Compuestos de 4-aminopirido[2,3-d]pirimidina 5, 6, 7-trisustituidos, el uso de los mismos para la manufactura de un medicamento, procedimiento para supreparacion, composicion farmaceutica que los comprende, compuestos intermediarios y procedimiento para su preparacion | |
AR040233A1 (es) | Polimorfos inhibidores de xantina fosfodiesterasa v | |
EA200100597A2 (ru) | Новые 1,1- и 1,2-дизамещенные циклопропановые соединения, способ их получения и содержащие их фармацевтические композиции | |
AR012435A1 (es) | Compuesto de 4-aminopirido[2,3-d]pirimidina 6,7-disustituida; el uso del mismo para la manufactura de un medicamento, procedimiento para su preparacion,composicion farmaceutica que lo contiene, compuestos intermediarios y procedimiento para su preparacion. | |
DE69122858D1 (de) | Therapeutische benzazepin verbindungen | |
MX9300423A (es) | Derivados heterociclicos. | |
RU96102846A (ru) | Производные изохинолина в качестве терапевтических средств | |
NZ222045A (en) | From diamides up to tetrapeptides for use as anticanvulsants | |
ES477257A1 (es) | Un procedimiento para preprarar derivados de isoquinoleina. | |
RU2021107688A (ru) | Трициклические соединения, действующие на белки crbn | |
UY28119A1 (es) | Nuevos derivados que contienen fosforo | |
KR970706258A (ko) | 4a-아릴데카히드로이소키노린 화합물 및 그 의약 용도(4a-ARYLDECAHYDROISOQUINOLIN COMPOUND AND MEDICINAL USE OF THE SAME) | |
AR030196A1 (es) | Compuesto que contiene cadena lateral carbociclica, composicion farmaceutica que lo contiene y uso de dicho compuesto para la fabricacion de un medicamento | |
GB1455617A (en) | Pyran derivatives | |
JPS57176910A (en) | Medicinal composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |